NOT-AI-13-042: Notice of Correction to Award Information in RFA-AI-13-024 Pharmacological Approaches to Evaluating Drug Regimens to Address Antimicrobial Resistance (R01)

Notice of Correction to Award Information in RFA-AI-13-024 "Pharmacological Approaches to Evaluating Drug Regimens to Address Antimicrobial Resistance (R01)"

Notice Number: NOT-AI-13-042

Key Dates

Release Date: May 1, 2013

Related Announcements

RFA-AI-13-024

Issued by

National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

This Notice corrects the language in RFA-AI-13-024 "Pharmacological Approaches to Evaluating Drug Regimens to Address Antimicrobial Resistance (R01)".

Part 2. Section II. Award Information

Funds Available and Anticipated Number of Awards: The NIAID intends to commit $5.5 million in total costs in FY 2014 to fund 6 to 10 applications in response to this FOA.

Award Budget: Application budgets need to reflect the actual needs of the proposed project and are limited to $750,000 direct costs in any year of the award.

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Christine Sizemore, Ph.D.
Division of Microbiology and Infectious Diseases
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 301-435-2857
Email: [email protected]